REGISTERED
on 24 Sep 2019
Last Applicant/ Owned by
660 W. Germantown Pike, Suite 110
Plymouth Meeting
PA
19462
Serial Number
88080254 filed on 15th Aug 2018
Registration Number
5865728 registered on 24th Sep 2019
Correspondent Address
Michael J. Leonard
Filing Basis
1. filed as use application
2. use application currently
Disclaimer
NO DATA
PENNVAX
Pharmaceutical compositions for the prevention and treatment of acquired immunodeficiency syndrome, cancer and infectious diseases; Nucleic acid sequences for medical purposes; Pharmaceutical compositions, namely, a nucleotide sequence that encodes an antigen, such as a DNA plasmid having an antigen encoding sequence and like DNA, for the prevention and treatment of acquired immunodeficiency syndr Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical compositions for the prevention and treatment of acquired immunodeficiency syndrome, cancer and infectious diseases; Nucleic acid sequences for medical purposes; Pharmaceutical compositions, namely, a nucleotide sequence that encodes an antigen, such as a DNA plasmid having an antigen encoding sequence and like DNA, for the prevention and treatment of acquired immunodeficiency syndrome (AIDS)
First Use Date in General
31st Jan 2011
First Use Date in Commerce
31st Jan 2011
Mark Details
Serial Number
No 88080254
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 114422.00042
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 24th Sep 2024 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 24th Sep 2019 | REGISTERED-PRINCIPAL REGISTER |
| 09th Jul 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 09th Jul 2019 | PUBLISHED FOR OPPOSITION |
| 19th Jun 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 31st May 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 31st May 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 31st May 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 31st May 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 07th Dec 2018 | NOTIFICATION OF PRIORITY ACTION E-MAILED |